Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Tannock

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The American Journal of Medicine|December 29, 1995
Will increases in chemotherapy dose intensity improve outcome of patients with common malignancies?I Tannock
Cancer Research|December 1, 1982
Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiationI Tannock
Cancer Treatment Reports|August 1, 1978
Cell kinetics and chemotherapy: a critical reviewI Tannock
Urology|September 1, 1980
Cis-platinum and hormones in cancer of prostateI Tannock
Cancer Research|May 1, 1983
Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycinI Tannock
Advances in Experimental Medicine and Biology|January 1, 1976
Oxygen distribution in tumours: influence on cell proliferation and implications for tumour therapyI Tannock
Cell and Tissue Kinetics|November 1, 1980
Cell kinetics-where to now?I Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trialsJ Baar, I Tannock
European Urology|January 1, 1988
Quality assessment of clinical trials in bladder cancerI Tannock, M Moore
Journal of the National Cancer Institute|August 3, 1988
Nonrandomized clinical trials of cancer chemotherapy: phase II or III?I Tannock, D Warr
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The American Journal of Medicine|December 29, 1995
Will increases in chemotherapy dose intensity improve outcome of patients with common malignancies?I Tannock
Cancer Research|December 1, 1982
Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiationI Tannock
Cancer Treatment Reports|August 1, 1978
Cell kinetics and chemotherapy: a critical reviewI Tannock
Urology|September 1, 1980
Cis-platinum and hormones in cancer of prostateI Tannock
Cancer Research|May 1, 1983
Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycinI Tannock
Advances in Experimental Medicine and Biology|January 1, 1976
Oxygen distribution in tumours: influence on cell proliferation and implications for tumour therapyI Tannock
Cell and Tissue Kinetics|November 1, 1980
Cell kinetics-where to now?I Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trialsJ Baar, I Tannock
European Urology|January 1, 1988
Quality assessment of clinical trials in bladder cancerI Tannock, M Moore
Journal of the National Cancer Institute|August 3, 1988
Nonrandomized clinical trials of cancer chemotherapy: phase II or III?I Tannock, D Warr
Pageof 5